Understanding Tick-Borne Diseases in Northern Italy
Insights Into Tick-Borne Diseases: a Prospective Study From an Endemic Area of Northern Italy
NA · IRCCS Sacro Cuore Don Calabria di Negrar · NCT06374615
This study is testing blood samples from people in Northern Italy who have had ticks removed to see if they have antibodies related to tick-borne diseases.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 384 (estimated) |
| Ages | 8 Years and up |
| Sex | All |
| Sponsor | IRCCS Sacro Cuore Don Calabria di Negrar (other) |
| Locations | 1 site (Negrar, Verona) |
| Trial ID | NCT06374615 on ClinicalTrials.gov |
What this trial studies
This study investigates tick-borne diseases in an endemic area of Northern Italy by analyzing blood samples from individuals who have had ticks removed. It is a monocentric, experimental study that involves additional visits and blood withdrawals beyond standard clinical practice. The focus is on detecting specific antibodies (IgG and IgM) related to tick-borne pathogens. The study aims to gather insights that could improve understanding and management of these diseases.
Who should consider this trial
Good fit: Ideal candidates include individuals over 8 years old who are presenting for tick removal and can provide informed consent.
Not a fit: Patients who do not have a tick available for analysis will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of tick-borne diseases, leading to better patient outcomes.
How similar studies have performed: While this study's specific approach may be novel, other studies have successfully explored tick-borne diseases, indicating potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all individuals aged \> 8 years presenting for tick removal. * Individuals providing signed informed consent. Exclusion Criteria: * tick not available for analysis
Where this trial is running
Negrar, Verona
- IRCCS Sacro Cuore Don Calabria hospital — Negrar, Verona, Italy (RECRUITING)
Study contacts
- Study coordinator: Elvia Malo
- Email: ricerca.clinica@sacrocuore.it
- Phone: +390456014854
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tick-Borne Diseases